Filing Details
- Accession Number:
- 0001209191-14-053388
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-19 16:30:26
- Reporting Period:
- 2014-08-18
- Filing Date:
- 2014-08-19
- Accepted Time:
- 2014-08-19 16:30:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1368148 | Athersys Inc / New | ATHX | Pharmaceutical Preparations (2834) | 204864095 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1352452 | Lorin Randall | 3201 Carnegie Avenue Cleveland OH 44115 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-08-18 | 15,000 | $1.35 | 15,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-08-18 | 15,000 | $1.54 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Director stock option (right to purchase) | Disposition | 2014-08-18 | 15,000 | $0.00 | 15,000 | $1.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-09-09 | No | 4 | M | Direct |
Footnotes
- Shares sold upon exercise of 2009 director stock option award prior to its expiration date on September 9, 2014.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.505 to $1.562, inclusive. The reporting person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The 2009 director stock option award became fully exercisable on September 9, 2012.